Our Pricing

Mounjaro Access at Cured Pharmacy: Complete UK Patient Guide

Published on: June 03, 2026

Understanding mounjaro price uk online pharmacy options helps you make informed decisions about weight loss treatment. At Cured Pharmacy, Mounjaro (tirzepatide) KwikPens start from £124.99, with transparent upfront pricing, free clinical consultations completed in under 3 minutes, and discreet next-day delivery across the UK. All treatments require assessment by our UK-registered prescribers to ensure clinical suitability and safety.

How Mounjaro Works for Weight Loss

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management in the UK [1]. Unlike single-pathway medications such as semaglutide, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously, producing enhanced effects on appetite regulation, insulin secretion, and energy expenditure.

In the landmark SURPASS-2 trial, participants receiving the 15mg tirzepatide dose achieved an average body weight reduction of 22.5% over 72 weeks, compared to 9.3% with semaglutide 1mg [1]. The dual-receptor mechanism appears to produce superior glycaemic control and greater reductions in body weight than GLP-1-only treatments, though individual responses vary based on adherence, lifestyle modifications, and metabolic factors [2].

Tirzepatide works by slowing gastric emptying, reducing appetite through central nervous system pathways, and improving insulin sensitivity. Patients typically report feeling fuller for longer periods and experiencing reduced cravings, which supports sustained calorie reduction when combined with dietary changes and increased physical activity [3].

Mounjaro Price UK: What You Pay at Cured Pharmacy

At Cured Pharmacy, Mounjaro KwikPens are available from £124.99, with final pricing determined by your prescribed dose following clinical assessment. Our transparent pricing model means you see exact costs before completing your consultation, with no hidden fees or subscription requirements.

Your UK-registered prescriber will determine the appropriate starting dose based on your medical history, current medications, weight loss goals, and any contraindications. Mounjaro follows a dose-escalation protocol, typically beginning at 2.5mg weekly for four weeks before gradually increasing to therapeutic doses of 5mg, 7.5mg, 10mg, 12.5mg, or 15mg as tolerated [4].

The price includes your medication, clinical consultation, prescription processing, and discreet delivery to your UK address. We guarantee the lowest prices in the UK for genuine, MHRA-licensed Mounjaro supplied directly from licensed wholesalers. All medications are stored in temperature-controlled facilities and dispatched in compliance with GPhC cold-chain requirements.

Transparent Pricing Before Consultation

Unlike some online services that reveal costs only after lengthy questionnaires, Cured Pharmacy displays upfront pricing for all weight loss treatments. This allows you to compare options and budget accordingly before investing time in the clinical assessment process. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), personally oversees all dispensing to ensure you receive authentic UK-licensed medications at competitive prices.

Mounjaro vs Wegovy: Clinical Differences Explained

Both Mounjaro and Wegovy are injectable weight loss medications licensed in the UK, but they utilise different mechanisms and demonstrate distinct efficacy profiles in clinical trials. Wegovy contains semaglutide, a GLP-1 receptor agonist that activates a single hormonal pathway, whereas Mounjaro's tirzepatide activates both GIP and GLP-1 receptors [1][5].

Head-to-head trial data from SURPASS-2 showed tirzepatide 15mg produced significantly greater weight reduction (12.4kg average) compared to semaglutide 1mg (6.2kg average) over 40 weeks in patients with type 2 diabetes [1]. In obesity-focused trials, the SURMOUNT-1 study demonstrated average weight loss of 20.9% with tirzepatide 15mg versus 14.9% with semaglutide 2.4mg in the STEP trials [2][5].

Both medications require once-weekly subcutaneous injection and share similar side effect profiles, predominantly gastrointestinal symptoms such as nausea, diarrhoea, and constipation, particularly during dose escalation. Your prescriber will consider your tolerance to GLP-1 medications, previous treatment responses, budget, and clinical goals when recommending the most suitable option.

Which Treatment Suits Your Needs?

Wegovy may be appropriate if you prefer a well-established GLP-1 treatment with extensive real-world safety data and a lower starting price point. Mounjaro may be recommended if you're seeking the potentially greater weight loss demonstrated in comparative trials or if you've experienced suboptimal results with single-pathway GLP-1 medications. Both require commitment to dietary modifications and increased physical activity for optimal outcomes.

Eligibility Criteria for Mounjaro in the UK

Mounjaro is licensed in the UK for adults with a body mass index (BMI) of 30 kg/m² or above, or 27 kg/m² or above with at least one weight-related comorbidity such as hypertension, type 2 diabetes, dyslipidaemia, or obstructive sleep apnoea [4]. Your prescriber will calculate your BMI during the online consultation and review your medical history to determine suitability.

Mounjaro is contraindicated in patients with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, or diabetic ketoacidosis. It should be used with caution in individuals with a history of pancreatitis, severe renal impairment, or those taking medications that affect gastric motility [4].

Pregnancy and breastfeeding are absolute contraindications, and women of childbearing potential should use effective contraception during treatment. If you're planning pregnancy, Mounjaro should be discontinued at least two months before conception due to the long half-life of tirzepatide. Your UK prescriber will discuss all relevant contraindications and precautions during your confidential consultation.

How to Access Mounjaro Through Cured Pharmacy

Accessing Mounjaro through Cured Pharmacy begins with a free online consultation that takes under 3 minutes to complete. You'll answer questions about your medical history, current medications, weight loss goals, previous treatments, and any contraindications. This information is reviewed by a UK-registered prescriber, typically within 24 hours on working days.

If Mounjaro is deemed clinically appropriate, your prescriber will issue a private prescription specifying the correct starting dose and titration schedule. Your medication is then dispensed by our GPhC-registered pharmacy (registration 9012511), packaged discreetly, and dispatched via temperature-controlled courier to maintain cold-chain integrity throughout transit.

You'll receive injection technique guidance, storage instructions, and information about managing potential side effects. Ongoing support is available via phone (+44 116 4646009) or email, and repeat prescriptions can be requested through your online account once your prescriber confirms continued suitability. Regular monitoring and dose adjustments are essential for safe, effective treatment.

What Happens After Your Consultation

Approved prescriptions are typically dispensed and dispatched within 24 hours on working days. You'll receive tracking information and cold-chain storage instructions via email. Mounjaro must be refrigerated at 2-8°C until first use, after which pens may be stored at room temperature (up to 30°C) for up to 21 days. Never freeze Mounjaro, and always inspect the solution before injection—it should be clear and colourless.

Managing Side Effects and Optimising Results

The most common side effects of Mounjaro are gastrointestinal, including nausea (reported in up to 29% of patients), diarrhoea (21%), vomiting (12%), and constipation (11%) in clinical trials [4]. These symptoms typically occur during dose escalation and diminish over time as your body adapts to the medication.

To minimise gastrointestinal discomfort, eat smaller, more frequent meals, avoid high-fat foods, stay well-hydrated, and allow your stomach to adjust to each dose increase before progressing. If side effects become severe or persistent, contact your prescriber—they may recommend slowing the titration schedule or adjusting your dose. Never increase your dose without prescriber approval.

Optimising weight loss outcomes requires combining Mounjaro with sustainable lifestyle changes. Clinical trial participants who achieved the greatest weight reductions also engaged in regular physical activity (minimum 150 minutes weekly of moderate-intensity exercise) and followed reduced-calorie diets [2][3]. Your prescriber can provide personalised guidance on nutrition, exercise, and behavioural strategies to maximise your results whilst on treatment.

When to Contact Your Prescriber

Seek immediate medical attention if you experience severe abdominal pain (which may indicate pancreatitis), persistent vomiting leading to dehydration, visual changes, or signs of thyroid tumours such as a lump in the neck or difficulty swallowing. Contact your prescriber if you experience hypoglycaemia symptoms (particularly if taking other diabetes medications), severe gastrointestinal symptoms lasting beyond the first month, or if you're not achieving expected weight loss after 12-16 weeks at therapeutic doses.

Scientific References

1. Frías, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., Liu, B., Cui, X., Brown, K. D., SURPASS-2 Investigators. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., Stefanski, A., SURMOUNT-1 Investigators. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–218. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
3. Wadden, T. A., Bailey, T. S., Billings, L. K., Davies, M., Frias, J. P., Koroleva, A., Lingvay, I., O'Neil, P. M., Rubino, D. M., Skovgaard, D., Wallenstein, S. O. R., Garvey, W. T., STEP 3 Investigators. (2021). Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity. JAMA, 325(14), 1403–1413. https://doi.org/10.1001/jama.2021.1831 [accessed 13 August 2026]
4. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC). https://www.medicines.org.uk/emc/product/14421/smpc [accessed 13 August 2026]
5. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., Kushner, R. F., STEP 1 Study Group. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and are not guaranteed. Mounjaro should be used as part of a comprehensive weight management programme including dietary modifications and increased physical activity.